AUBAGIO: payments to doctors
Payments that named AUBAGIO as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $11.9M
- Providers
- 6,375
- Transactions
- 55,061
- Average per transaction
- $216
The per-transaction average — $216 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 6,375 providers the average total is $1,867, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Sanofi | $11,377,455 | 95.6% |
| Sanofi-aventis U.S. LLC | $523,272 | 4.4% |
| Sanofi US Services Inc. | $1,489 | 0.0% |